Pharmafile Logo
Pharmafocus logo
Advanced Search

price hikes

Showing 11 posts of 11 posts found.

shutterstock_512649

J&J joins in on industry price hiking; almost 500 drug prices increased in 2019 so far

January 11, 2019
Medical Communications, Sales and Marketing J&J, JJ, Stelara, US, Xarelto, Zytiga, pharma, price hikes

It’s only the second week of the New Year, and Johnson & Johnson has announced plans to hike the prices …

News

Pfizer to resume price hiking in 2019; 41 drugs set to increase

November 20, 2018
Manufacturing and Production, Sales and Marketing Pfizer, Trump, pharma, price hikes, price hiking, pricing

American pharma firm Pfizer has revealed plans to increase the prices of 41 medicines, the equivalent of 10% of its …

News

AstraZeneca announces price freezes while earnings drop by 28%

July 26, 2018
Business Services, Sales and Marketing AstraZeneca, Trump, price freezes, price hikes

The Anglo-Swedish drug maker AstraZeneca has joined Pfizer and others in halting price hikes until the end of 2018. AstraZeneca …

News
merckwindow_web

Merck joins Pizer and Novartis in reducing drug prices

July 20, 2018
Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes

Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …

News
donald_trump_29496131773

Donald Trump thanks Novartis for halting price hikes

July 20, 2018
Medical Communications Novartis, Pfizer, Trump, Twitter, price hikes

Donald Trump has thanked Swiss multinational Novartis for halting price hikes on prescription drugs in the United States. The US …

News
shutterstock_138095450

Unfazed by Trump, Pfizer hikes prices for 100 of its drugs

July 3, 2018
Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes

After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …

News
shutterstock_274590824

PhRMA launches lawsuit against the state of California over anti-price hike bill

December 11, 2017
Sales and Marketing Drug pricing, PhRMA, california, pharma, price hikes

The state of California has become the target of legal action after the lobbying group Pharmaceutical Research and Manufacturers of …

News
19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

Feature
shutterstock_57369385

NHS suppliers investigated over 1000% price hikes

October 26, 2016
Research and Development, Sales and Marketing NHS, price hikes

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …

News
hils

Clinton announces plan to tackle “unjustified price hikes”

September 5, 2016
Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes

US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …

News
valeant

Valeant’s outgoing CEO subpoenaed by US congressional committee

March 29, 2016
Medical Communications, Research and Development Drug pricing, Michael Pearson, US, Valeant, committee, pearson, pharma, price hikes, senate aging committee, subpoena, subpoenaed

The US Senate Aging Committee has announced the issuing of a subpoena to the outgoing CEO of Valeant Pharmaceuticals, Michael …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024